Skip to main content
. 2013 Mar 12;108(7):1525–1533. doi: 10.1038/bjc.2013.107

Table 2. Characteristics of the cancer survivors and SIR for diagnosesa.

  No. of 5-year survivors (%) Attendance benefitsObs./SIR (95% CI) Basic benefitsObs./SIR (95% CI) Disability pensionObs./SIR (95% CI) Medical rehabilitation benefitsObs./SIR (95% CI) All combinedbObs./SIR (95% CI)
Gender
Male 2232 (55.4) 202/15.7 (13.4–17.6) 233/9.9 (8.7–11.2) 161/5.2 (4.5–6.1) 198/1.4 (1.2–1.6) 607/4.7 (4.4–5.1)
Female
1799 (44.6)
163/21.7 (18.7–25.4)
209/8.9 (7.7–10.2)
178/5.7 (5.1–6.3)
207/1.2 (1.0–1.4)
592/4.1 (3.8–4.5)
Year of birth
1965–1969 977 (24.2) 43/11.6 (8.4–15.6) 95/4.9 (4.0–6.0) 122/3.9 (3.3–4.7) 108/0.9 (0.7–1.1) 265/2.0 (1.7–2.2)
1970–1974 1038 (25.8) 54/15.6 (11.7–20.4) 105/8.9 (7.3–10.8) 111/6.3 (5.1–7.5) 116/1.1 (0.9–1.4) 256/3.3 (2.9–3.7)
1975–1979 1027 (25.5) 105/18.5 (15.3–22.4) 115/12.9 (10.8–15.5) 75/9.7 (7.5–12.0) 103/1.6 (1.3–2.0) 297/7.2 (6.5–8.1)
1980–1985
989 (24.5)
163/24.1 (20.7–28.1)
127/16.5 (13.8–19.6)
31/7.7 (5.2–11.0)
78/2.5 (2.0–3.1)
381/18.7 (16.9–20.6)
Age at primary cancer diagnosis
0–14 1470 (36.5) 301/18.3 (16.4–20.5) 281/9.7 (8.5–10.7) 167/5.9 (4.6–7.3) 135/1.1 (0.9–1.3) 573/5.4 (4.9–5.8)
15–19 1019 (25.3) 34/17.9 (12.4–25.0) 82/8.9 (7.1–11.1) 70/4.5 (3.5–5.7) 111/1.4 (1.2–1.7) 264/3.9 (3.5–4.4)
20–24
1542 (38.3)
30/24.2 (23.2–33.1)
79/9.3 (7.3–11.5)
102/5.2 (4.3–6.3)
159/1.4 (1.2–1.6)
362/3.6 (3.3–4.0)
Calendar year of primary cancer diagnosis
1965–1974 185 (4.6) 10/8.8 (4.2–16.2) 25/5.3 (3.4–7.8) 27/4.4 (2.9–6.4) 20/0.9 (0.6–1.5) 51/2.0 (1.5–2.7)
1975–1984 753 (18.7) 91/9.2 (7.4–11.3) 107/5.5 (4.5–6.6) 95/5.5 (4.4–6.7) 67/0.9 (0.7–1.1) 214/2.8 (2.4–3.2)
1985–1994 1681 (41.7) 224/27.6 (24.2–31.4) 241/11.4 (10.1–13.0) 178/5.6 (4.8–6.4) 175/1.0 (0.9–1.2) 588/4.2 (3.9–4.6)
1995–1904
1412 (35.0)
40/87.5 (62.5–119.2)
69/34.5 (26.8–43.7)
39/7.7 (5.5–10.5)
144/2.7 (2.3–3.2)
346/10.2 (9.2–11.3)
Primary cancer site (ICD-7 codes)
Kidney (180.0) 108 (2.7) 13/9.0 (4.8–15.5) 9/3.5 (1.6–6.7) 5/2.2 (0.7–5.2) 7/0.7 (0.3–1.4) 22/2.0 (1.3–3.1)
Eye (192) 90 (2.2) 24/18.5 (11.9–27.6) 18/8.4 (5.0–13.2) 7/3.9 (1.6–8.0) 11/1.4 (0.7–2.5) 38/5.2 (3.6–7.0)
Brain/nervous system (193) 733 (18.2) 130/28.3 (23.8–33.6) 134/13.4 (11.3–15.9) 150/15.2 (12.9–17.8) 90/1.7 (1.3–2.1) 311/7.7 (6.9–8.6)
Thyroid gland and other endocrine glands (194–195) 295 (7.3) 20/20.3 (12.4–31.4) 28/9.6 (6.4–13.8) 31/7.2 (4.9–10.3) 38/1.7 (1.2–2.3) 87/4.4 (3.5–5.4)
Bone and connective tissue (196–197) 226 (5.6) 40/38.5 (27.5–52.4) 81/29.0 (23.0–36.1) 18/5.0 (3.0–7.9) 34/1.9 (1.3–2.7) 122/10.8 (9.1–12.9)
Lymphatic system (206) 581 (14.4) 20/13.1 (8.1–20.3) 35/6.7 (4.6–9.3) 32/3.8 (2.6–5.3) 67/1.5 (1.1–1.9) 177/4.6 (4.0–5.9)
Haematopoietic system (207) 519 (12.9) 89/16.3 (13.1–20.3) 81/8.8 (7.0–10.9) 33/4.2 (2.9–5.8) 43/1.1 (0.8–1.4) 206/6.1 (5.3–7.0)
Cervix uteri (171) 50 (1.2) 0/0 (0–58.5) 1/2.4 (0.1–13.3) 4/4.2 (1.2–10.8) 12/2.4 (1.3–4.3) 17/3.7 (2.2–6.0)
Ovary (175) 82 (2.0) 2/9.4 (1.1–34.1) 4/4.6 (1.3–11.8) 5/3.4 (1.1–7.9) 6/0.9 (0.3–1.9) 17/2.5 (1.4–3.9)
Testis (178) 622 (15.4) 11/10.1 (5.0–18.0) 21/4.8 (2.8–7.0) 25/3.0 (1.8–3.4) 44/0.9 (0.7–1.2) 91/2.1 (1.7–2.6)
Melanoma (190) 427 (10.6) 3/4.0 (0.8–11.7) 7/1.9 (0.8–4.0) 12/1.7 (0.9–2.9) 33/0.9 (0.6–1.2) 49/1.3 (1.0–1.8)
Other
298 (7.4)
13/11.1 (5.3–17.9)
23/7.5 (4.5–10.9)
17/3.9 (2.1–6.0)
20/0.8 (0.5–1.3)
62/2.9 (2.2–3.7)
Total 4031 (100.0) 365/17.9 (16.3–20.0) 442/9.3 (8.5–10.3) 339/5.6 (5.0–6.2) 405/1.3 (1.1–1.4) 1199/4.4 (4.1–4.6)

Abbreviations: CI=confidence interval; ICD-7=International Classification of Diseases-7; obs.=observed; SIR=standardised incidence ratio.

a

Obtained from social security benefits available from 1992 to 2006 (2002–2007 for medical rehabilitation benefits).

b

Here any survivor who received a social security benefit was included. Survivors with more than one social security benefit uptake were counted only once.